FEMY
FEMASYS INC
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$2.59
+1.57%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$2.55
From 52W high−87.55%
Volume35027.00
Market cap$21.69M
P/E (TTM)—
P/S (TTM)9.4x
Div yield—
Key dataSep 18, 2026
Open
$2.55
From 52W high
−87.55%
Volume
35027.00
Market cap
$21.69M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−2.6x
P/E (TTM)
—
RSI (14)
41.6
MomentumView details →
1D Return
+1.57%
YTD Return
−77.69%
SummaryUpdated Jun 1, 2026
Femasys Inc. (NASDAQ:FEMY) is a biomedical company founded in 2004 and headquartered in Suwanee, Georgia, that specializes in developing and commercializing medical devices for women's healthcare. The company went public in June 2021 and focuses on creating innovative solutions for reproductive health, including permanent birth control, fertility treatments, and diagnostic procedures. Femasys operates in the medical devices sector, specifically targeting the underserved women's healthcare market with proprietary technologies designed to provide minimally invasive alternatives to traditional surgical procedures.
Similar companies
Latest newsMore news →
Femasys Inc. announced that Minnesota Women's Care will implement FemVue for fertility diagnostic evaluation and FemaSeed Complete for in-office first-line fertility treatment across its four OB/GYN practice locations.5d agoFemasys Inc. announced a partnership with CapexMD to expand patient access to its FemaSeed fertility portfolio through dedicated financing solutions.11d agoFemasys Inc. announced a partnership with UNC Health to introduce its fertility products FemVue, SpermVue, and FemaSeed Complete across UNC Health OB/GYN practice locations.25d ago